Actively Recruiting
Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid Arthritis
Led by Alexandria University · Updated on 2025-04-25
80
Participants Needed
1
Research Sites
163 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Evaluating the effect of the flavonoids combination (diosmin and hesperidin) as adjuvant therapy on patients with rheumatoid arthritis
CONDITIONS
Official Title
Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid Arthritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with mild to moderate disease activity.
- Patient age must be more than 18 years.
You will not qualify if you...
- Pregnant and lactating females.
- Patients with liver, renal impairment or any other inflammatory diseases.
- Patients on TNF-alpha (tumor necrosis factor-alpha) or IL-1beta (interleukin-1beta) antagonists.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Alexandria university hospital
Alexandria, Egypt
Actively Recruiting
Research Team
A
AHMED ABDELBAR, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here